These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 25504649

  • 21. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY, Stevenson LW, Stewart GC, Bhatt DL, Desai M, Seeger JD, Williams L, Jalbert JJ, Setoguchi S.
    BMJ; 2015 Jul 14; 351():h3529. PubMed ID: 26174233
    [Abstract] [Full Text] [Related]

  • 22. Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
    Hess PL, Hellkamp AS, Peterson ED, Sanders GD, Al-Khalidi HR, Curtis LH, Hammill BG, Pun PH, Curtis JP, Anstrom KJ, Hammill SC, Al-Khatib SM.
    Circ Arrhythm Electrophysiol; 2014 Oct 14; 7(5):793-9. PubMed ID: 25038119
    [Abstract] [Full Text] [Related]

  • 23. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM, Sobrino-Márquez JM, Grande-Trillo A, Lage-Gallé E, Rangel-Sousa D, Esteve-Ruiz IM, Martínez-Martínez A.
    Transplant Proc; 2013 Oct 14; 45(10):3659-61. PubMed ID: 24314988
    [Abstract] [Full Text] [Related]

  • 24. Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry.
    Providência R, Marijon E, Lambiase PD, Bouzeman A, Defaye P, Klug D, Amet D, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Piot O, Boveda S.
    J Am Heart Assoc; 2016 Feb 12; 5(2):. PubMed ID: 26873687
    [Abstract] [Full Text] [Related]

  • 25. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V, Perault R, Bories MC, Narayanan K, Garcia R, Combes N, Perier MC, Defaye P, Sadoul N, Gras D, Klug D, Bordachar P, Fauchier L, Deharo JC, Leclercq C, Boveda S, Marijon E, Babuty D, DAI-PP investigatorsParis Descartes University, 75006 Paris, France..
    Arch Cardiovasc Dis; 2018 Dec 12; 111(12):758-765. PubMed ID: 30078651
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.
    DeWitt ES, Triedman JK, Cecchin F, Mah DY, Abrams DJ, Walsh EP, Gauvreau K, Alexander ME.
    Circ Arrhythm Electrophysiol; 2014 Dec 12; 7(6):1057-63. PubMed ID: 25262116
    [Abstract] [Full Text] [Related]

  • 29. Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.
    Hess PL, Hernandez AF, Bhatt DL, Hellkamp AS, Yancy CW, Schwamm LH, Peterson ED, Schulte PJ, Fonarow GC, Al-Khatib SM.
    Circulation; 2016 Aug 16; 134(7):517-26. PubMed ID: 27492903
    [Abstract] [Full Text] [Related]

  • 30. Primary prevention implantable cardioverter-defibrillators and survival in older women.
    Zeitler EP, Hellkamp AS, Fonarow GC, Hammill SC, Curtis LH, Hernandez AF, Al-Khalidi HR, Curtis JP, Heidenreich PA, Anstrom KJ, Peterson ED, Mark DB, Hammill BG, Sanders GD, Al-Khatib SM.
    JACC Heart Fail; 2015 Feb 16; 3(2):159-67. PubMed ID: 25543969
    [Abstract] [Full Text] [Related]

  • 31. Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis.
    Kong MH, Al-Khatib SM, Sanders GD, Hasselblad V, Peterson ED.
    Cardiol J; 2011 Feb 16; 18(5):503-14. PubMed ID: 21947985
    [Abstract] [Full Text] [Related]

  • 32. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D, Stros P, Curila K, Kebza V, Osmancik P.
    Europace; 2013 Jul 16; 15(7):963-9. PubMed ID: 23447573
    [Abstract] [Full Text] [Related]

  • 33. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
    Defaye P, Boveda S, Klug D, Beganton F, Piot O, Narayanan K, Périer MC, Gras D, Fauchier L, Bordachar P, Algalarrondo V, Babuty D, Deharo JC, Leclercq C, Marijon E, Sadoul N, DAI-PP Investigators.
    Europace; 2017 Sep 01; 19(9):1478-1484. PubMed ID: 28340096
    [Abstract] [Full Text] [Related]

  • 34. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N, Boveda S, Defaye P, Klug D, Treguer F, Amet D, Perier MC, Gras D, Algalarrondo V, Bouzeman A, Piot O, Deharo JC, Fauchier L, Babuty D, Bordachar P, Sadoul N, Marijon E, Leclercq C, DAI-PP Investigators.
    Europace; 2018 Jan 01; 20(1):65-72. PubMed ID: 28082419
    [Abstract] [Full Text] [Related]

  • 35. Longitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry).
    Daimee UA, Aslam F, Parzynski CS, Desai NR, Curtis JP.
    Am J Cardiol; 2021 Sep 15; 155():64-71. PubMed ID: 34315569
    [Abstract] [Full Text] [Related]

  • 36. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
    Akel T, Lafferty J.
    Cardiovasc Ther; 2017 Jun 15; 35(3):. PubMed ID: 28129469
    [Abstract] [Full Text] [Related]

  • 37. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Jordan CP, Freedenberg V, Wang Y, Curtis JP, Gleva MJ, Berul CI.
    Circ Arrhythm Electrophysiol; 2014 Dec 15; 7(6):1092-100. PubMed ID: 25287482
    [Abstract] [Full Text] [Related]

  • 38. Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators: Insights From the National Cardiovascular Data Registry.
    Baskar S, Bao H, Minges KE, Spar DS, Czosek RJ.
    Circ Arrhythm Electrophysiol; 2018 Sep 15; 11(9):e006542. PubMed ID: 30354291
    [Abstract] [Full Text] [Related]

  • 39. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN, Greenlee RT, Go AS, Magid DJ, Cassidy-Bushrow A, Garcia-Montilla R, Glenn KA, Gurwitz JH, Hammill SC, Hayes J, Kadish A, Reynolds K, Sharma P, Smith DH, Varosy PD, Vidaillet H, Zeng CX, Normand ST, Masoudi FA.
    J Am Heart Assoc; 2017 Nov 09; 6(11):. PubMed ID: 29122811
    [Abstract] [Full Text] [Related]

  • 40. Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients.
    Zhang Y, Blasco-Colmenares E, Harms AC, London B, Halder I, Singh M, Dudley SC, Gutmann R, Guallar E, Hankemeier T, Tomaselli GF, Cheng A.
    Europace; 2016 Sep 09; 18(9):1383-90. PubMed ID: 26498162
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.